ETRACS 2x Leveraged US Growth Factor TR ETN
IWFL
0 hedge funds and large institutions have $0 invested in ETRACS 2x Leveraged US Growth Factor TR ETN in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1.19K → $0 (-$1.19K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| – | -$1.19K | -33 | Closed |
|
IWFL Hedge Fund Activity: Q2 2024 in Review
0 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) for Q2 2024, worth a combined $0 — down 100% from $1.19K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IWFL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $1.19K sold.
- 0 institutional investors held ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) as of Q2 2024, down from 1 in Q1 2024.
- Funds reported $0 of ETRACS 2x Leveraged US Growth Factor TR ETN stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged US Growth Factor TR ETN positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN seller in Q2 2024 was UBS Group, an estimated $1.19K sold.
Based on aggregated 13F filings for Q2 2024.